Stocks and Investing Stocks and Investing
Mon, October 14, 2019
Fri, October 11, 2019

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $104 on, Oct 11th, 2019


Published on 2024-10-26 16:51:20 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $136 to $104 on, Oct 11th, 2019.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Initiated at Hold and Held Target at $109 on, Tuesday, October 1st, 2019


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $160 on, Tuesday, June 18th, 2019
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $163 on, Monday, June 17th, 2019

Contributing Sources